カテゴリー： Market Monitor Global, 世界, 医療/バイオ

結核（TB）用BCGワクチンの世界市場見通し2023年-2029年

◆英語タイトル：BCG Vaccine for Tuberculosis (TB) Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5709）

◆商品コード：MMG23JU5709
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：114
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global BCG Vaccine for Tuberculosis (TB) Market 調査レポートは次の情報を含め、グローバルにおけるの結核（TB）用BCGワクチン市場規模と予測を収録しています。・世界の結核（TB）用BCGワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の結核（TB）用BCGワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の結核（TB）用BCGワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「免疫用」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

結核（TB）用BCGワクチンのグローバル主要企業は、Merck、 Sanofi Pasteur、 Japan BCG Lab、 China National Biotec、 AJ Vaccines、 Serum Institute of India、 Intervax、 GSBPL、 Statens Serum Institute、 Biomed Lublin、 ANLIS Malbran、 Fundação Ataulpho de Paiva、 BB-NCIPD、 Taj Pharmaceuticals、 Bio Farma、 Microgen、 Torlakinstitut、 Institut Pasteur de Tunis、 IVACなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、結核（TB）用BCGワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の結核（TB）用BCGワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の結核（TB）用BCGワクチン市場：タイプ別市場シェア、2022年
・免疫用、治療用

世界の結核（TB）用BCGワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の結核（TB）用BCGワクチン市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の結核（TB）用BCGワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の結核（TB）用BCGワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における結核（TB）用BCGワクチンのグローバル売上、2018年-2023年
・主要企業における結核（TB）用BCGワクチンのグローバル売上シェア、2022年
・主要企業における結核（TB）用BCGワクチンのグローバル販売量、2018年-2023年
・主要企業における結核（TB）用BCGワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Merck、 Sanofi Pasteur、 Japan BCG Lab、 China National Biotec、 AJ Vaccines、 Serum Institute of India、 Intervax、 GSBPL、 Statens Serum Institute、 Biomed Lublin、 ANLIS Malbran、 Fundação Ataulpho de Paiva、 BB-NCIPD、 Taj Pharmaceuticals、 Bio Farma、 Microgen、 Torlakinstitut、 Institut Pasteur de Tunis、 IVAC

*************************************************************

・調査・分析レポートの概要
結核（TB）用BCGワクチン市場の定義
市場セグメント
世界の結核（TB）用BCGワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の結核（TB）用BCGワクチン市場規模
世界の結核（TB）用BCGワクチン市場規模：2022年 VS 2029年
世界の結核（TB）用BCGワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの結核（TB）用BCGワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の結核（TB）用BCGワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：免疫用、治療用
結核（TB）用BCGワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
結核（TB）用BCGワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別結核（TB）用BCGワクチン市場規模 2022年と2029年
地域別結核（TB）用BCGワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Merck、 Sanofi Pasteur、 Japan BCG Lab、 China National Biotec、 AJ Vaccines、 Serum Institute of India、 Intervax、 GSBPL、 Statens Serum Institute、 Biomed Lublin、 ANLIS Malbran、 Fundação Ataulpho de Paiva、 BB-NCIPD、 Taj Pharmaceuticals、 Bio Farma、 Microgen、 Torlakinstitut、 Institut Pasteur de Tunis、 IVAC
...

BCG Vaccine for Tuberculosis (TB) provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.
This report aims to provide a comprehensive presentation of the global market for BCG Vaccine for Tuberculosis (TB), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BCG Vaccine for Tuberculosis (TB). This report contains market size and forecasts of BCG Vaccine for Tuberculosis (TB) in global, including the following market information:
Global BCG Vaccine for Tuberculosis (TB) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global BCG Vaccine for Tuberculosis (TB) Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five BCG Vaccine for Tuberculosis (TB) companies in 2022 (%)
The global BCG Vaccine for Tuberculosis (TB) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Immune Type Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of BCG Vaccine for Tuberculosis (TB) include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, AJ Vaccines, Serum Institute of India, Intervax, GSBPL and Statens Serum Institute, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the BCG Vaccine for Tuberculosis (TB) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global BCG Vaccine for Tuberculosis (TB) Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global BCG Vaccine for Tuberculosis (TB) Market Segment Percentages, by Type, 2022 (%)
Immune Type
Therapy Type
Global BCG Vaccine for Tuberculosis (TB) Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global BCG Vaccine for Tuberculosis (TB) Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global BCG Vaccine for Tuberculosis (TB) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global BCG Vaccine for Tuberculosis (TB) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies BCG Vaccine for Tuberculosis (TB) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies BCG Vaccine for Tuberculosis (TB) revenues share in global market, 2022 (%)
Key companies BCG Vaccine for Tuberculosis (TB) sales in global market, 2018-2023 (Estimated), (K Units)
Key companies BCG Vaccine for Tuberculosis (TB) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
Intervax
GSBPL
Statens Serum Institute
Biomed Lublin
ANLIS Malbran
Fundação Ataulpho de Paiva
BB-NCIPD
Taj Pharmaceuticals
Bio Farma
Microgen
Torlakinstitut
Institut Pasteur de Tunis
IVAC
Outline of Major Chapters:
Chapter 1: Introduces the definition of BCG Vaccine for Tuberculosis (TB), market overview.
Chapter 2: Global BCG Vaccine for Tuberculosis (TB) market size in revenue and volume.
Chapter 3: Detailed analysis of BCG Vaccine for Tuberculosis (TB) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of BCG Vaccine for Tuberculosis (TB) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global BCG Vaccine for Tuberculosis (TB) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 BCG Vaccine for Tuberculosis (TB) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global BCG Vaccine for Tuberculosis (TB) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global BCG Vaccine for Tuberculosis (TB) Overall Market Size
2.1 Global BCG Vaccine for Tuberculosis (TB) Market Size: 2022 VS 2029
2.2 Global BCG Vaccine for Tuberculosis (TB) Revenue, Prospects & Forecasts: 2018-2029
2.3 Global BCG Vaccine for Tuberculosis (TB) Sales: 2018-2029
3 Company Landscape
3.1 Top BCG Vaccine for Tuberculosis (TB) Players in Global Market
3.2 Top Global BCG Vaccine for Tuberculosis (TB) Companies Ranked by Revenue
3.3 Global BCG Vaccine for Tuberculosis (TB) Revenue by Companies
3.4 Global BCG Vaccine for Tuberculosis (TB) Sales by Companies
3.5 Global BCG Vaccine for Tuberculosis (TB) Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 BCG Vaccine for Tuberculosis (TB) Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers BCG Vaccine for Tuberculosis (TB) Product Type
3.8 Tier 1, Tier 2 and Tier 3 BCG Vaccine for Tuberculosis (TB) Players in Global Market
3.8.1 List of Global Tier 1 BCG Vaccine for Tuberculosis (TB) Companies
3.8.2 List of Global Tier 2 and Tier 3 BCG Vaccine for Tuberculosis (TB) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global BCG Vaccine for Tuberculosis (TB) Market Size Markets, 2022 & 2029
4.1.2 Immune Type
4.1.3 Therapy Type
4.2 By Type – Global BCG Vaccine for Tuberculosis (TB) Revenue & Forecasts
4.2.1 By Type – Global BCG Vaccine for Tuberculosis (TB) Revenue, 2018-2023
4.2.2 By Type – Global BCG Vaccine for Tuberculosis (TB) Revenue, 2024-2029
4.2.3 By Type – Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share, 2018-2029
4.3 By Type – Global BCG Vaccine for Tuberculosis (TB) Sales & Forecasts
4.3.1 By Type – Global BCG Vaccine for Tuberculosis (TB) Sales, 2018-2023
4.3.2 By Type – Global BCG Vaccine for Tuberculosis (TB) Sales, 2024-2029
4.3.3 By Type – Global BCG Vaccine for Tuberculosis (TB) Sales Market Share, 2018-2029
4.4 By Type – Global BCG Vaccine for Tuberculosis (TB) Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global BCG Vaccine for Tuberculosis (TB) Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global BCG Vaccine for Tuberculosis (TB) Revenue & Forecasts
5.2.1 By Application – Global BCG Vaccine for Tuberculosis (TB) Revenue, 2018-2023
5.2.2 By Application – Global BCG Vaccine for Tuberculosis (TB) Revenue, 2024-2029
5.2.3 By Application – Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share, 2018-2029
5.3 By Application – Global BCG Vaccine for Tuberculosis (TB) Sales & Forecasts
5.3.1 By Application – Global BCG Vaccine for Tuberculosis (TB) Sales, 2018-2023
5.3.2 By Application – Global BCG Vaccine for Tuberculosis (TB) Sales, 2024-2029
5.3.3 By Application – Global BCG Vaccine for Tuberculosis (TB) Sales Market Share, 2018-2029
5.4 By Application – Global BCG Vaccine for Tuberculosis (TB) Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global BCG Vaccine for Tuberculosis (TB) Market Size, 2022 & 2029
6.2 By Region – Global BCG Vaccine for Tuberculosis (TB) Revenue & Forecasts
6.2.1 By Region – Global BCG Vaccine for Tuberculosis (TB) Revenue, 2018-2023
6.2.2 By Region – Global BCG Vaccine for Tuberculosis (TB) Revenue, 2024-2029
6.2.3 By Region – Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share, 2018-2029
6.3 By Region – Global BCG Vaccine for Tuberculosis (TB) Sales & Forecasts
6.3.1 By Region – Global BCG Vaccine for Tuberculosis (TB) Sales, 2018-2023
6.3.2 By Region – Global BCG Vaccine for Tuberculosis (TB) Sales, 2024-2029
6.3.3 By Region – Global BCG Vaccine for Tuberculosis (TB) Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America BCG Vaccine for Tuberculosis (TB) Revenue, 2018-2029
6.4.2 By Country – North America BCG Vaccine for Tuberculosis (TB) Sales, 2018-2029
6.4.3 US BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.4.4 Canada BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.4.5 Mexico BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe BCG Vaccine for Tuberculosis (TB) Revenue, 2018-2029
6.5.2 By Country – Europe BCG Vaccine for Tuberculosis (TB) Sales, 2018-2029
6.5.3 Germany BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.5.4 France BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.5.5 U.K. BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.5.6 Italy BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.5.7 Russia BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.5.8 Nordic Countries BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.5.9 Benelux BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia BCG Vaccine for Tuberculosis (TB) Revenue, 2018-2029
6.6.2 By Region – Asia BCG Vaccine for Tuberculosis (TB) Sales, 2018-2029
6.6.3 China BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.6.4 Japan BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.6.5 South Korea BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.6.6 Southeast Asia BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.6.7 India BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America BCG Vaccine for Tuberculosis (TB) Revenue, 2018-2029
6.7.2 By Country – South America BCG Vaccine for Tuberculosis (TB) Sales, 2018-2029
6.7.3 Brazil BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.7.4 Argentina BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa BCG Vaccine for Tuberculosis (TB) Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales, 2018-2029
6.8.3 Turkey BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.8.4 Israel BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.8.5 Saudi Arabia BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
6.8.6 UAE BCG Vaccine for Tuberculosis (TB) Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.1.4 Merck BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Sanofi Pasteur
7.2.1 Sanofi Pasteur Company Summary
7.2.2 Sanofi Pasteur Business Overview
7.2.3 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.2.4 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.2.5 Sanofi Pasteur Key News & Latest Developments
7.3 Japan BCG Lab
7.3.1 Japan BCG Lab Company Summary
7.3.2 Japan BCG Lab Business Overview
7.3.3 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.3.4 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.3.5 Japan BCG Lab Key News & Latest Developments
7.4 China National Biotec
7.4.1 China National Biotec Company Summary
7.4.2 China National Biotec Business Overview
7.4.3 China National Biotec BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.4.4 China National Biotec BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.4.5 China National Biotec Key News & Latest Developments
7.5 AJ Vaccines
7.5.1 AJ Vaccines Company Summary
7.5.2 AJ Vaccines Business Overview
7.5.3 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.5.4 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.5.5 AJ Vaccines Key News & Latest Developments
7.6 Serum Institute of India
7.6.1 Serum Institute of India Company Summary
7.6.2 Serum Institute of India Business Overview
7.6.3 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.6.4 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.6.5 Serum Institute of India Key News & Latest Developments
7.7 Intervax
7.7.1 Intervax Company Summary
7.7.2 Intervax Business Overview
7.7.3 Intervax BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.7.4 Intervax BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.7.5 Intervax Key News & Latest Developments
7.8 GSBPL
7.8.1 GSBPL Company Summary
7.8.2 GSBPL Business Overview
7.8.3 GSBPL BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.8.4 GSBPL BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.8.5 GSBPL Key News & Latest Developments
7.9 Statens Serum Institute
7.9.1 Statens Serum Institute Company Summary
7.9.2 Statens Serum Institute Business Overview
7.9.3 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.9.4 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.9.5 Statens Serum Institute Key News & Latest Developments
7.10 Biomed Lublin
7.10.1 Biomed Lublin Company Summary
7.10.2 Biomed Lublin Business Overview
7.10.3 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.10.4 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.10.5 Biomed Lublin Key News & Latest Developments
7.11 ANLIS Malbran
7.11.1 ANLIS Malbran Company Summary
7.11.2 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Business Overview
7.11.3 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.11.4 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.11.5 ANLIS Malbran Key News & Latest Developments
7.12 Fundação Ataulpho de Paiva
7.12.1 Fundação Ataulpho de Paiva Company Summary
7.12.2 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Business Overview
7.12.3 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.12.4 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.12.5 Fundação Ataulpho de Paiva Key News & Latest Developments
7.13 BB-NCIPD
7.13.1 BB-NCIPD Company Summary
7.13.2 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Business Overview
7.13.3 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.13.4 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.13.5 BB-NCIPD Key News & Latest Developments
7.14 Taj Pharmaceuticals
7.14.1 Taj Pharmaceuticals Company Summary
7.14.2 Taj Pharmaceuticals Business Overview
7.14.3 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.14.4 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.14.5 Taj Pharmaceuticals Key News & Latest Developments
7.15 Bio Farma
7.15.1 Bio Farma Company Summary
7.15.2 Bio Farma Business Overview
7.15.3 Bio Farma BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.15.4 Bio Farma BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.15.5 Bio Farma Key News & Latest Developments
7.16 Microgen
7.16.1 Microgen Company Summary
7.16.2 Microgen Business Overview
7.16.3 Microgen BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.16.4 Microgen BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.16.5 Microgen Key News & Latest Developments
7.17 Torlakinstitut
7.17.1 Torlakinstitut Company Summary
7.17.2 Torlakinstitut Business Overview
7.17.3 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.17.4 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.17.5 Torlakinstitut Key News & Latest Developments
7.18 Institut Pasteur de Tunis
7.18.1 Institut Pasteur de Tunis Company Summary
7.18.2 Institut Pasteur de Tunis Business Overview
7.18.3 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.18.4 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.18.5 Institut Pasteur de Tunis Key News & Latest Developments
7.19 IVAC
7.19.1 IVAC Company Summary
7.19.2 IVAC Business Overview
7.19.3 IVAC BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.19.4 IVAC BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2018-2023)
7.19.5 IVAC Key News & Latest Developments
8 Global BCG Vaccine for Tuberculosis (TB) Production Capacity, Analysis
8.1 Global BCG Vaccine for Tuberculosis (TB) Production Capacity, 2018-2029
8.2 BCG Vaccine for Tuberculosis (TB) Production Capacity of Key Manufacturers in Global Market
8.3 Global BCG Vaccine for Tuberculosis (TB) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 BCG Vaccine for Tuberculosis (TB) Supply Chain Analysis
10.1 BCG Vaccine for Tuberculosis (TB) Industry Value Chain
10.2 BCG Vaccine for Tuberculosis (TB) Upstream Market
10.3 BCG Vaccine for Tuberculosis (TB) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 BCG Vaccine for Tuberculosis (TB) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of BCG Vaccine for Tuberculosis (TB) in Global Market
Table 2. Top BCG Vaccine for Tuberculosis (TB) Players in Global Market, Ranking by Revenue (2022)
Table 3. Global BCG Vaccine for Tuberculosis (TB) Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global BCG Vaccine for Tuberculosis (TB) Revenue Share by Companies, 2018-2023
Table 5. Global BCG Vaccine for Tuberculosis (TB) Sales by Companies, (K Units), 2018-2023
Table 6. Global BCG Vaccine for Tuberculosis (TB) Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers BCG Vaccine for Tuberculosis (TB) Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers BCG Vaccine for Tuberculosis (TB) Product Type
Table 9. List of Global Tier 1 BCG Vaccine for Tuberculosis (TB) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 BCG Vaccine for Tuberculosis (TB) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global BCG Vaccine for Tuberculosis (TB) Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global BCG Vaccine for Tuberculosis (TB) Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global BCG Vaccine for Tuberculosis (TB) Sales (K Units), 2018-2023
Table 15. By Type - Global BCG Vaccine for Tuberculosis (TB) Sales (K Units), 2024-2029
Table 16. By Application – Global BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global BCG Vaccine for Tuberculosis (TB) Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global BCG Vaccine for Tuberculosis (TB) Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global BCG Vaccine for Tuberculosis (TB) Sales (K Units), 2018-2023
Table 20. By Application - Global BCG Vaccine for Tuberculosis (TB) Sales (K Units), 2024-2029
Table 21. By Region – Global BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global BCG Vaccine for Tuberculosis (TB) Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global BCG Vaccine for Tuberculosis (TB) Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global BCG Vaccine for Tuberculosis (TB) Sales (K Units), 2018-2023
Table 25. By Region - Global BCG Vaccine for Tuberculosis (TB) Sales (K Units), 2024-2029
Table 26. By Country - North America BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America BCG Vaccine for Tuberculosis (TB) Sales, (K Units), 2018-2023
Table 29. By Country - North America BCG Vaccine for Tuberculosis (TB) Sales, (K Units), 2024-2029
Table 30. By Country - Europe BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe BCG Vaccine for Tuberculosis (TB) Sales, (K Units), 2018-2023
Table 33. By Country - Europe BCG Vaccine for Tuberculosis (TB) Sales, (K Units), 2024-2029
Table 34. By Region - Asia BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia BCG Vaccine for Tuberculosis (TB) Sales, (K Units), 2018-2023
Table 37. By Region - Asia BCG Vaccine for Tuberculosis (TB) Sales, (K Units), 2024-2029
Table 38. By Country - South America BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America BCG Vaccine for Tuberculosis (TB) Sales, (K Units), 2018-2023
Table 41. By Country - South America BCG Vaccine for Tuberculosis (TB) Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales, (K Units), 2024-2029
Table 46. Merck Company Summary
Table 47. Merck BCG Vaccine for Tuberculosis (TB) Product Offerings
Table 48. Merck BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. Sanofi Pasteur Company Summary
Table 51. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Product Offerings
Table 52. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Sanofi Pasteur Key News & Latest Developments
Table 54. Japan BCG Lab Company Summary
Table 55. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product Offerings
Table 56. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Japan BCG Lab Key News & Latest Developments
Table 58. China National Biotec Company Summary
Table 59. China National Biotec BCG Vaccine for Tuberculosis (TB) Product Offerings
Table 60. China National Biotec BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. China National Biotec Key News & Latest Developments
Table 62. AJ Vaccines Company Summary
Table 63. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product Offerings
Table 64. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. AJ Vaccines Key News & Latest Developments
Table 66. Serum Institute of India Company Summary
Table 67. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product Offerings
Table 68. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Serum Institute of India Key News & Latest Developments
Table 70. Intervax Company Summary
Table 71. Intervax BCG Vaccine for Tuberculosis (TB) Product Offerings
Table 72. Intervax BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Intervax Key News & Latest Developments
Table 74. GSBPL Company Summary
Table 75. GSBPL BCG Vaccine for Tuberculosis (TB) Product Offerings
Table 76. GSBPL BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. GSBPL Key News & Latest Developments
Table 78. Statens Serum Institute Company Summary
Table 79. Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Product Offerings
Table 80. Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Statens Serum Institute Key News & Latest Developments
Table 82. Biomed Lublin Company Summary
Table 83. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product Offerings
Table 84. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Biomed Lublin Key News & Latest Developments
Table 86. ANLIS Malbran Company Summary
Table 87. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product Offerings
Table 88. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. ANLIS Malbran Key News & Latest Developments
Table 90. Fundação Ataulpho de Paiva Company Summary
Table 91. Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Offerings
Table 92. Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Fundação Ataulpho de Paiva Key News & Latest Developments
Table 94. BB-NCIPD Company Summary
Table 95. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product Offerings
Table 96. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. BB-NCIPD Key News & Latest Developments
Table 98. Taj Pharmaceuticals Company Summary
Table 99. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product Offerings
Table 100. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Taj Pharmaceuticals Key News & Latest Developments
Table 102. Bio Farma Company Summary
Table 103. Bio Farma BCG Vaccine for Tuberculosis (TB) Product Offerings
Table 104. Bio Farma BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Bio Farma Key News & Latest Developments
Table 106. Microgen Company Summary
Table 107. Microgen BCG Vaccine for Tuberculosis (TB) Product Offerings
Table 108. Microgen BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Microgen Key News & Latest Developments
Table 110. Torlakinstitut Company Summary
Table 111. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product Offerings
Table 112. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Torlakinstitut Key News & Latest Developments
Table 114. Institut Pasteur de Tunis Company Summary
Table 115. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product Offerings
Table 116. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Institut Pasteur de Tunis Key News & Latest Developments
Table 118. IVAC Company Summary
Table 119. IVAC BCG Vaccine for Tuberculosis (TB) Product Offerings
Table 120. IVAC BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. IVAC Key News & Latest Developments
Table 122. BCG Vaccine for Tuberculosis (TB) Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 123. Global BCG Vaccine for Tuberculosis (TB) Capacity Market Share of Key Manufacturers, 2021-2023
Table 124. Global BCG Vaccine for Tuberculosis (TB) Production by Region, 2018-2023 (K Units)
Table 125. Global BCG Vaccine for Tuberculosis (TB) Production by Region, 2024-2029 (K Units)
Table 126. BCG Vaccine for Tuberculosis (TB) Market Opportunities & Trends in Global Market
Table 127. BCG Vaccine for Tuberculosis (TB) Market Drivers in Global Market
Table 128. BCG Vaccine for Tuberculosis (TB) Market Restraints in Global Market
Table 129. BCG Vaccine for Tuberculosis (TB) Raw Materials
Table 130. BCG Vaccine for Tuberculosis (TB) Raw Materials Suppliers in Global Market
Table 131. Typical BCG Vaccine for Tuberculosis (TB) Downstream
Table 132. BCG Vaccine for Tuberculosis (TB) Downstream Clients in Global Market
Table 133. BCG Vaccine for Tuberculosis (TB) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. BCG Vaccine for Tuberculosis (TB) Segment by Type in 2022
Figure 2. BCG Vaccine for Tuberculosis (TB) Segment by Application in 2022
Figure 3. Global BCG Vaccine for Tuberculosis (TB) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global BCG Vaccine for Tuberculosis (TB) Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global BCG Vaccine for Tuberculosis (TB) Revenue, 2018-2029 (US$, Mn)
Figure 7. BCG Vaccine for Tuberculosis (TB) Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by BCG Vaccine for Tuberculosis (TB) Revenue in 2022
Figure 9. By Type - Global BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share, 2018-2029
Figure 11. By Type - Global BCG Vaccine for Tuberculosis (TB) Sales Market Share, 2018-2029
Figure 12. By Type - Global BCG Vaccine for Tuberculosis (TB) Price (US$/Unit), 2018-2029
Figure 13. By Application - Global BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share, 2018-2029
Figure 15. By Application - Global BCG Vaccine for Tuberculosis (TB) Sales Market Share, 2018-2029
Figure 16. By Application - Global BCG Vaccine for Tuberculosis (TB) Price (US$/Unit), 2018-2029
Figure 17. By Region - Global BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share, 2018-2029
Figure 20. By Region - Global BCG Vaccine for Tuberculosis (TB) Sales Market Share, 2018-2029
Figure 21. By Country - North America BCG Vaccine for Tuberculosis (TB) Revenue Market Share, 2018-2029
Figure 22. By Country - North America BCG Vaccine for Tuberculosis (TB) Sales Market Share, 2018-2029
Figure 23. US BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2029
Figure 24. Canada BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe BCG Vaccine for Tuberculosis (TB) Revenue Market Share, 2018-2029
Figure 27. By Country - Europe BCG Vaccine for Tuberculosis (TB) Sales Market Share, 2018-2029
Figure 28. Germany BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2029
Figure 29. France BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2029
Figure 31. Italy BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2029
Figure 32. Russia BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia BCG Vaccine for Tuberculosis (TB) Revenue Market Share, 2018-2029
Figure 36. By Region - Asia BCG Vaccine for Tuberculosis (TB) Sales Market Share, 2018-2029
Figure 37. China BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2029
Figure 38. Japan BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2029
Figure 41. India BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America BCG Vaccine for Tuberculosis (TB) Revenue Market Share, 2018-2029
Figure 43. By Country - South America BCG Vaccine for Tuberculosis (TB) Sales Market Share, 2018-2029
Figure 44. Brazil BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa BCG Vaccine for Tuberculosis (TB) Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales Market Share, 2018-2029
Figure 48. Turkey BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2029
Figure 49. Israel BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2029
Figure 51. UAE BCG Vaccine for Tuberculosis (TB) Revenue, (US$, Mn), 2018-2029
Figure 52. Global BCG Vaccine for Tuberculosis (TB) Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production BCG Vaccine for Tuberculosis (TB) by Region, 2022 VS 2029
Figure 54. BCG Vaccine for Tuberculosis (TB) Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 結核（TB）用BCGワクチンの世界市場見通し2023年-2029年(BCG Vaccine for Tuberculosis (TB) Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

結核（TB）用BCGワクチンの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp